DTC
NMRA icon

Deep Track Capital’s Neumora Therapeutics NMRA Stock Holding History

Deep Track Capital’s Portfolio NMRA Stock Details NMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,189,800
Closed -$12.6M – 75
2024
Q4 		$12.6M Buy
1,189,800
+1,009,300
+559% +$12.1M 0.47% 46
2024
Q3 		$2.38M Hold
180,500
– – 0.08% 65
2024
Q2 		$1.77M Buy
+180,500
New +$1.87M 0.05% 68

Other funds holding NMRA

SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
LC
Lunate Capital Al Maryah Island, Abu Dhabi, United Arab Emirates $196M AUM 84.21% 1-Year Est. Return

Deep Track Capital's NMRA Position: Q1 2025 in Review

Deep Track Capital sold out of Neumora Therapeutics (NMRA) in Q1 2025, closing a stake of 4,000,000 shares — an estimated $42.4M sold.

Deep Track Capital first reported a position in NMRA in Q1 2024 and held it in 3 quarters. The position peaked at $42.4M in Q4 2024. 115 funds tracked by Wall St. Rank hold NMRA as of Q1 2025.

  • Deep Track Capital reported no remaining Neumora Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Deep Track Capital sold 4,000,000 Neumora Therapeutics shares in Q1 2025, an estimated $42.4M.
  • Deep Track Capital first reported a position in Neumora Therapeutics in Q1 2024 and held it in 3 quarters.
  • Deep Track Capital's Neumora Therapeutics position peaked at $42.4M in Q4 2024.
  • 115 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q1 2025.

Based on Deep Track Capital's 13F filing for Q1 2025, filed 15 May 2025.